Interpretation of the updates of the Chinese guidelines for the diagnosis and treatment of primary liver cancer (CNLC-2024 Edition)

被引：0

作者：

Su, Hao ^{[1
]}

Wei, Yongguang ^{[1
,2
,3
]}

Liao, Xiwen ^{[1
]}

Zhu, Guangzhi ^{[1
]}

Peng, Minhao ^{[1
]}

Fan, Fang ^{[4
]}

Peng, Tao ^{[1
,2
,3
]}

机构：

[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Nanning 530021, Guangxi, Peoples R China

[2] Guangxi Key Lab Enhanced Recovery Surg Gastrointes, Nanning 530021, Guangxi, Peoples R China

[3] Guangxi Med Univ, Key Lab High Incidence Tumor Prevent & Treatment, Minist Educ, Nanning 530021, Guangxi, Peoples R China

[4] Guangxi Med Univ, Tumor Hosp, Dept Continued Educ, Nanning 530021, Guangxi, Peoples R China

来源：

HEPATOMA RESEARCH | 2024年 / 10卷

基金：

中国国家自然科学基金;

关键词：

Primary liver cancer; hepatocellular carcinoma; guidelines; update; interpretation; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; UNRESECTABLE HEPATOCELLULAR-CARCINOMA; PORTAL-VEIN; OPEN-LABEL; 1ST-LINE TREATMENT; SORAFENIB; THERAPY; MULTICENTER; PLUS; EMBOLIZATION;

D O I：

10.20517/2394-5079.2024.70

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Additional randomized controlled studies and high-level evidence for the diagnosis and management of liver cancer patients have been published since the release of Diagnosis and Treatment of Primary Liver Cancer Guidelines (CNLC-2022 edition). The 2024 version algorithm was updated accordingly by the national expert committee for the standardization and homogenization of liver cancer diagnosis and treatment in China. In this review, with reference to the guidelines of the 2022 version, we interpreted the main update points of the 2024 version to facilitate the nationwide dissemination and implementation of the guidelines.

引用

页数：12

共 102 条

[1] Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer) [J].

Abou-Alfa, Ghassan K. ;

Lau, George ;

Kudo, Masatoshi ;

Chan, Stephen L. ;

Kelley, Robin Kate ;

Furuse, Junji ;

Sukeepaisarnjaroen, Wattana ;

Kang, Yoon Koo ;

Dao, Tu Van ;

De Toni, Enrico N. ;

Rimassa, Lorenza ;

Breder, Valeriy ;

Vasilyev, Alexander ;

Heurgue, Alexandra ;

Tam, Vincent C. ;

Mody, Kabir ;

Thungappa, Satheesh Chiradoni ;

Ostapenko, Yurii ;

Yau, Thomas ;

Azevedo, Sergio ;

Varela, Maria ;

Cheng, Ann-Lii ;

Qin, Shukui ;

Galle, Peter R. ;

Ali, Sajid ;

Gupta, Charu ;

Makowsky, Mallory ;

Kurland, John F. ;

Negro, Alejandra ;

Sangro, Bruno .

FUTURE ONCOLOGY, 2023, 19 (38) :2505-2516

[2] Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid [J].

Barr, Richard G. ;

Huang, Pintong ;

Luo, Yan ;

Xie, Xiaoyan ;

Zheng, Rongqin ;

Yan, Kun ;

Jing, Xiang ;

Luo, Yukun ;

Xu, Huixiong ;

Fei, Xiang ;

Lee, Jeong Min .

ABDOMINAL RADIOLOGY, 2020, 45 (11) :3779-3788

[3] Hepatobiliary Cancers, Version 2.2021 [J].

Benson III, Al B. ;

D'Angelica, Michael I. ;

Abbott, Daniel E. ;

Anaya, Daniel A. ;

Anders, Robert ;

Are, Chandrakanth ;

Bachini, Melinda ;

Borad, Mitesh ;

Brown, Daniel ;

Burgoyne, Adam ;

Chahal, Prabhleen ;

Chang, Daniel T. ;

Cloyd, Jordan ;

Covey, Anne M. ;

Glazer, Evan S. ;

Goyal, Lipika ;

Hawkins, William G. ;

Iyer, Renuka ;

Jacob, Rojymon ;

Kelley, R. Kate ;

Kim, Robin ;

Levine, Matthew ;

Palta, Manisha ;

Park, James O. ;

Raman, Steven ;

Reddy, Sanjay ;

Sahai, Vaibhav ;

Schefter, Tracey ;

Singh, Gagandeep ;

Stein, Stacey ;

Vauthey, Jean-Nicolas ;

Venook, Alan P. ;

Yopp, Adam ;

McMillian, Nicole R. ;

Hochstetler, Cindy ;

Darlow, Susan D. .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (05) :541-565

[4] Phase 1 Trial of Sorafenib and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma [J].

Brade, Anthony M. ;

Ng, Sylvia ;

Brierley, James ;

Kim, John ;

Dinniwell, Robert ;

Ringash, Jolie ;

Wong, Rebecca R. ;

Cho, Charles ;

Knox, Jennifer ;

Dawson, Laura A. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (03) :580-587

[5] Systemic treatment of hepatocellular carcinoma: An EASL position paper [J].

Bruix, Jordi ;

Chan, Stephen L. ;

Galle, Peter R. ;

Rimassa, Lorenza ;

Sangro, Bruno .

JOURNAL OF HEPATOLOGY, 2021, 75 (04) :960-974

[6] Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial [J].

Bruix, Jordi ;

Qin, Shukui ;

Merle, Philippe ;

Granito, Alessandro ;

Huang, Yi-Hsiang ;

Bodoky, Gyrogy ;

Pracht, Marc ;

Yokosuka, Osamu ;

Rosmorduc, Olivier ;

Breder, Valeriy ;

Gerolami, Rene ;

Masi, Gianluca ;

Ross, Paul J. ;

Song, Tianqiang ;

Bronowicki, Jean-Pierre ;

Ollivier-Hourmand, Isabelle ;

Kudo, Masatoshi ;

Cheng, Ann-Lii ;

Llovet, Josep M. ;

Finn, Richard S. ;

LeBerre, Marie-Aude ;

Baumhauer, Annette ;

Meinhardt, Gerold ;

Han, Guohong .

LANCET, 2017, 389 (10064) :56-66

[7] Dose escalation by intensity modulated radiotherapy in liver-directed concurrent chemoradiotherapy for locally advanced BCLC stage C hepatocellular carcinoma [J].

Byun, Hwa Kyung ;

Kim, Hyun Ju ;

Im, Yoo Ri ;

Kim, Do Young ;

Han, Kwang-Hyub ;

Seong, Jinsil .

RADIOTHERAPY AND ONCOLOGY, 2019, 133 :1-8

[8] Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection [J].

Chan, Anthony W. H. ;

Zhong, Jianhong ;

Berhane, Sarah ;

Toyoda, Hidenori ;

Cucchetti, Alessandro ;

Shi, KeQing ;

Tada, Toshifumi ;

Chong, Charing C. N. ;

Xiang, Bang-De ;

Li, Le-Qun ;

Lai, Paul B. S. ;

Mazzaferro, Vincenzo ;

Garcia-Finana, Marta ;

Kudo, Masatoshi ;

Kumada, Takashi ;

Roayaie, Sasan ;

Johnson, Philip J. .

JOURNAL OF HEPATOLOGY, 2018, 69 (06) :1284-1293

[9] Role of radiotherapy in Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma treated with sorafenib [J].

Chang, Won Ick ;

Kim, Byoung Hyuck ;

Kim, Yoon Jun ;

Yoon, Jung-Hwan ;

Jung, Yong Jin ;

Chie, Eui Kyu .

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (02) :387-394

[10] Clinical efficacy and safety of external radiotherapy combined with sorafenib in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis [J].

Chen, Jiali ;

He, Kun ;

Han, Yunwei ;

Guo, Lu ;

Su, Ke ;

Wu, Zhenying .

ANNALS OF HEPATOLOGY, 2022, 27 (04)

← 1 2 3 4 5 6 7 8 9 10 →